Home
Conditions
Large B-cell Lymphoma

Clinical trial condition

Large B-cell Lymphoma

Explore clinical trials studying Large B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

60 public trials 36 recruiting studies

Refine in advanced search Browse all conditions

Large B-cell Lymphoma trial results

Active, not recruiting

Study of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Lymphoma

NCT05757700

Conditions: B-cell Lymphoma, DLBCL, Nos Genetic Subtypes, Hemic and Lymphatic Diseases, +12 more
Locations: Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States

View Trial Details

Active, not recruiting

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

NCT05020678

Conditions: Aggressive Lymphoma, B-cell Acute Lymphoblastic Leukemia, Blood Protein Disorders, +43 more
Locations: Colorado Blood Cancer Institute Denver, Colorado, United States

The Cleveland Clinic Foundation Cleveland, Ohio, United States

Institute of Haematology, Royal Prince Alfred Hospital Camperdown, New South Wales, Australia

St. Vincent's Hospital Sydney, New South Wales, Australia

View Trial Details

Active, not recruiting

MT2017-45: CAR-T Cell Therapy for Heme Malignancies

NCT03642626

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Active, not recruiting

Mosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Patients With Relapsed/Refractory Aggressive B Cell Lymphoma

NCT05464329

Conditions: Follicular Lymphoma Grade 3B, High-grade B-cell Lymphoma, Large B-cell Lymphoma, +1 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Active, not recruiting

PD-L1 PET-imaging During CAR T-cell Therapy

NCT05404048

Conditions: Large B-cell Lymphoma
Locations: University Medical Center Groningen Groningen, Netherlands

View Trial Details

Active, not recruiting

Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID)

NCT06285422

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
Locations: The University of Kansas Hospital Kansas City, Kansas, United States

Swedish Cancer Institute Seattle, Washington, United States

Fred Hutchinson Cancer Center Seattle, Washington, United States

View Trial Details

Completed

Sequential CD19/CD22 CAR-T Cell Therapy Following ASCT

NCT07236151

Conditions: Auto Stem Cell Transplant, CAR T Cell Therapy, Large B-cell Lymphoma
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Completed

CNCT19 Following ASCT in Patients With Relapsed or Refractory B-cell Lymphoma

NCT04690192

Conditions: Large B-cell Lymphoma
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Completed

89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL)

NCT04566978

Conditions: DLBCL, Large B-cell Lymphoma
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting

NCT05108805

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Large B-cell Lymphoma

Large B-cell Lymphoma trial results

Related conditions